Pulsus Group invites all the participants from all over the world to attend “24th International Conference on Vaccine Design, Production & Safety” to be held on May 21-22, 2018, Vienna, Austria. Vaccine Design 2018 focuses on the theme “Deliberation on modern vaccine research and development focusing on vaccine design delivery and evaluation “which aims in gathering the eminent research communities catalyzing information exchange and networking between researchers and business entrepreneurs of diverse backgrounds fostering advancements in Vaccine Design research
PULSUS has acknowledged you as a world class expert capable of providing deep insight into the latest developments in your field. Basing on your eminence and expertise in the field, we are honored to invite as an Organizing Committee Member for Vaccine Design 2018 this will allow reflecting on the Vaccine Design, Production & Safety at 360 degrees, all-round by expanding the knowledge of everyone.
Pulsus Group invites all the participants from all over the world to attend “24th International Conference on Vaccine Design, Production & Safety” to be held on May 21-22, 2018, Vienna, Austria. Vaccine Design 2018 is based on the theme “Deliberation on modern vaccine research and development focusing on vaccine design, delivery and evaluation”. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
The aim of Vaccine Design 2018 is to bring together leading academic Scientists, Researchers, professors, Business delegates, talented student communities and research scholars to commerce and share their experiences and research conclusion about all aspects of Vaccine Design & Development and its safety.
Vaccine Design 2018 hosting presentations from Global Leaders in the field across the Globe and bringing together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers.
Vaccine Design 2018
Theme: “Deliberation on modern vaccine research and development focusing on vaccine design, delivery and evaluation”.
Traditionally Vaccines have been used to eradicate infectious diseases, which started with Small Pox. Apparently In the last few years there is great advancement towards vaccine design and its development. In the Era of Molecular biology the innovative technologies such as genomics, proteomics, and functional genomics are used for the rational identification of antigens, generation of engineered carrier proteins and much more. The research in this area has always been more exciting with ever new outbreak the nature throws from influenza to Zika.
For more details please visit- http://vaccinedesign.cmesociety.com/
Importance and Scope
“24th International Conference on Vaccine Design, Production & Safety” to be held on May 21-22, 2018, Vienna, Austria hosted by Pulsus Group, the conference will explore the advances in Vaccine Research, Development & Design. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on Vaccines and its safety, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.
- Vaccines Research and Production Technology
- Vaccine Design & Development
- Conjugate vaccines
- Vaccine Development and Implementation
- Public Health Effectiveness of Vaccine Implementation
- Vaccines for infants, children, and adult
- Vaccines Storage and Handling
- Bacterial vaccines
- Vaccine Efficacy and Safety
- Vaccine adjuvants
- Plant derived vaccines
- Vaccines and vaccination
- Vaccine Safety, Surveillance and Evaluation
- Vaccine Industries
- Immunization Safety and Vaccination Schedule
Vaccine Global Market:
The vaccines market has been drastically growing, the in the last decade where there is a huge leap from 6 billion USD in 2000 to 33 billion USD in 2014 it is expected to reach 48.03 Billion by 2021(Fig2). Going on the basis of Molecular technology, the vaccines market is projected to a have drastic growth in next few years. The market share is dominated by High Income Countries with 61%, upper and Lower middle income countries with 23% and 8% respectively and Low income countries with 6 %( Fig.1). There are lots of other Emerging manufacturers from India, China, Brazil who are playing vital role and contributing to the market share (Fig.3). The government support and other funding bodies are into vaccine development and there is indeed progress in this business &investments will drive the growth of this market segment.
Why to attend???
Vaccine Design 2018 is intended to provide a notable opening to the experts in the field of Vaccine Research & Development & its Safety to discuss latest research and challenges in the arena. Vaccine Design 2018 is planned to provide a special podium for health-care professionals, researchers, Business delegates and students working in the arena to consciously, exchange visions and their understandings in front of a large intercontinental listeners. This Vaccine Design, Production & Safety conferences, Vaccine events and Vaccine meetings will help in interaction with different brains in Vaccine Research & Development, B2B construction between specialists and academicians. The companies dealing with Vaccine products and supplements can exhibit their products in the Vaccine exhibition and expo.
Medical Colleges Faculty, Students
Immunology Associations and Societies
Vaccines Training Institutes
Software developing companies
Manufacturing Medical Devices Companies
Clinical Data Management Companies
Machinery Manufacturing Companies
Track 3: Vaccine Production & Development
Track 4: Conjugate Vaccines
Track 9: Vaccines Storage and Handling
Track 10: Bacterial Vaccines
Track 11: Vaccine Efficacy and Safety
Track 12: Vaccine Adjuvants
Track 13: Plant derived Vaccines
Track 14: Vaccines against Drugs
Track 15: Vaccines and Vaccination
Track 17: Vaccine Industries
Track 20: Current Research & Future Challenges
Track 21: HPV Vaccines:
Track 22: Plant-based vaccines: